Virtu Financial LLC Makes New Investment in Cardinal Health, Inc. $CAH

Virtu Financial LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 3,127 shares of the company’s stock, valued at approximately $642,000.

Several other institutional investors have also made changes to their positions in CAH. Aventura Private Wealth LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $25,000. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust bought a new stake in Cardinal Health in the fourth quarter worth approximately $27,000. Palladiem LLC bought a new stake in Cardinal Health in the fourth quarter worth approximately $28,000. Finally, Elyxium Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth $34,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.6%

Shares of Cardinal Health stock opened at $223.11 on Tuesday. The firm has a fifty day simple moving average of $204.48 and a 200-day simple moving average of $209.41. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock has a market capitalization of $52.25 billion, a price-to-earnings ratio of 34.11, a PEG ratio of 1.21 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CAH shares. William Blair assumed coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Robert W. Baird set a $248.00 target price on Cardinal Health in a report on Friday, May 1st. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 15th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.